The global 3D cell culture market size was estimated at USD 1.70 billion in 2024 and is expected to grow at a CAGR of 11.72% from 2025 to 2030. The market's growth can be attributed to the rising efforts to develop potential alternatives to animal-based testing and the availability of funding programs for research. Moreover, other factors anticipated to fuel market growth over the projected period are consistent efforts in R&D activities by biopharmaceutical companies for drug development & discovery and emphasis on the adoption of 3D cell cultures in cancer research. Animal models are largely used in cellular-based studies to study various diseases' outlook. However, they carry several demerits, such as a lack of response accuracy, differences in response from different species, etc. Thus, to manage these issues, various government organizations are involved in promoting alternative ways for drug development.
The increasing focus on developing alternatives to animal testing is significantly driving the growth of the 3D cell culture industry. There is growing awareness and concern regarding the ethical implications of using animals for research. The principles of the 3Rs (Replacement, Reduction, and Refinement) advocate for minimizing animal use in scientific research. As a result, there is a strong push towards finding more humane alternatives, such as 3D cell culture systems, which can provide relevant biological insights without the ethical dilemmas associated with animal testing.
Moreover, the rising burden of chronic diseases and medical ailments, such as multiple organ failure, has created a robust demand for organ transplants. Meanwhile, the dearth of donors has propelled the demand for alternative solutions, such as regenerative medicine and tissue engineering. The 3D cell cultures system is important in nurturing organoids and functional tissue constructs for transplantation and drug analysis responses. Moreover, companies are launching products that would significantly boost the applications for tissue culture and tissue engineering. For instance, in June 2023, 3D BioFibR launched two novel 3D bioprinting collagen fiber products (CollaFibR 3D scaffold and μCollaFibR) for improved 3D cell culture.
Pharmaceutical companies, academic institutions, and research institutes are partnering to advance 3D cell culture technology. Such efforts accelerate technology advancement, knowledge sharing, and standardization of protocols, resulting in the larger adoption of 3D cell culture techniques. In addition, supportive government legislation and funding from public and private organizations have accelerated the R&D activities in the industry. For instance, in March 2023, ZEISS Ventures invested in InSphero to promote 3D cell culture research. Similarly, in November 2023, HeartBeat.bio invested USD 4.94 million (€4.5 million) to develop a specific type of platform which is 3D human tissue-based drug discovery for heart diseases.
Furthermore, robust demand for in-vitro testing models from a range of end users, and several organic and inorganic initiatives undertaken by industry players is anticipated to facilitate market expansion in coming years. For instance, in December 2023, Charles River Laboratories announced their agreement with CELLphenomics, which is anticipated to expand their 3D in vitro services that would be used for drug screening purposes for cancer therapy. Similarly, in October 2020 Merck collaborated with D1 Med to accelerate manufacturing of D1Med’s 3-dimensional cells culture technology applications adopted in the drug development process.
The COVID-19 pandemic had a significant impact on the 3D cell culture industry. The COVID-19 pandemic has given researchers the opportunity to investigate the novel contagious virus to create therapeutic and diagnostic tools. Numerous prominent pharmaceutical and biotechnology companies have engaged in extensive R&D efforts to produce innovative vaccines, therapies, and testing kits. As a result, there has been a substantial increase in the need for cell culture tools in research applications. Furthermore, the pandemic has increased the demand for new cell-based models, organoids, and high-throughput screening platforms for research & drug discovery efforts. The urgency to combat the pandemic increased the demand for bioreactors and culture systems for vaccine production and drug testing applications.
The growth stage is medium, and the pace is accelerating in the industry. The 3D cell culture industry is characterized by a high degree of innovation owing to rapid technological advancements. Moreover, the emergence of a microfluidics-based 3D cell model (a type of cell culture) has further fueled the growth of the 3D cell culture industry. Several pharmaceutical companies & researchers are using this platform for better accuracy, and it is a reliable model for toxicity testing and drug screening. In May 2023, CellFE announced the launch of a new microfluidics cellular engineering platform, Infinity Mtx, at the annual meeting of the American Society of Cell and Gene Therapy (ASGCT) 2023.
The 3D cell culture industry is also characterized by a high level of partnerships and collaboration activity undertaken by the leading players. This is attributed to the rising focus on increasing the company’s products & services portfolio, the need to consolidate in a rapidly growing industry, and the increasing strategic importance of 3D cell models. Several companies are undertaking this strategy to strengthen their portfolio. For instance, in May 2023, Kiyatec and AstraZeneca announced their collaboration for multifaceted research using Kiyatec’s 3D spheroid screening platform, KIYA-Predict, to develop and commercialize new therapeutics for cancer.
Regulatory authorities are focusing on establishing stringent guidelines for biosafety, contamination control, cell line authentication, and other factors. Hence, compliance with regulatory standards represents significant challenges that may limit market growth. 3D cell model products intended for clinical or commercial use must comply with regulatory authorities' rigorous quality and safety standards. These standards may include Good Manufacturing Practices (GMPs) and quality control measures to ensure the final products' consistency, purity, and safety. Meeting these regulatory requirements necessitates meticulous documentation and validation of procedures, which can increase the complexity and cost of cell culture operations. These factors may lead to limited adoption of 3D cell culture techniques and restrict market growth.
Several companies are expanding their 3D cell culture products. Thus, product expansion in the 3D cell culture industry is significant. Companies are including product launches that specifically use 3D cell models for research purposes that are anticipated to drive market growth. For instance, in December 2023, Inventia Life Science introduced a new product, Inventia Third Dimension Grant. This is projected to assist researchers with their studies regarding drug development or fundamental biology to model and test assumptions using 3D cell culture technology.
The regional expansion scenario in the 3D cell culture industry presents significant growth opportunities across diverse regions, each with its unique characteristics and challenges. North America and Europe lead the market with strong research and regulatory support. In contrast, the Asia-Pacific, Latin American, and Middle East regions offer emerging growth potential, driven by expanding biotechnology sectors and increased investments in healthcare and research. Successful regional expansion requires tailored strategies that address local market needs, regulatory environments, and economic conditions.
The scaffold-based segment held the largest revenue share of 48.85% in 2024. The segment is divided into hydrogels, polymeric scaffolds, micropatterned surfaced microplates, and nanofiber-based scaffolds. Factors such as increasing application of scaffold-based cultures in tissue engineering and regenerative medicine applications, advancements in scaffold materials and fabrication techniques, and increasing research funding and collaboration are anticipated to drive segment growth. Hydrogels as a scaffold in 3D cell culture model studies allow the incorporation of biochemical and mechanical signs as a mirror of the native extracellular matrix.
In addition, technological advancements, ongoing research activities, and recent product launches are projected to fuel segment growth. In June 2022, Dolomite Bio launched novel hydrogel-focused reagent kits for high-throughput encapsulation of cells in hydrogel scaffold. Furthermore, ongoing research efforts to develop scaffold-based technologies support 3D cell culture market expansion. For instance, in May 2023, researchers from NUS successfully used common plant protein to 3D print an edible cell culture scaffold.
The scaffold-free segment is expected to register the highest CAGR from 2025 to 2030. Factors such as enhanced cellular interactions, higher throughput and scalability, rising demand for personalized medicine, and advancements in 3D culture model platforms and technologies are responsible for the fastest growth of the segment. In addition, robust demand for scaffold-free systems across end users such as the biopharmaceutical industry and research institutes is another factor catering to segment demand
The stem cell research & tissue engineering segment dominated the market with a share of 34.23% in 2024. The market is segmented into cancer research, stem cell research & tissue engineering, drug development & toxicity testing, and others. The key factors contributing to segment growth are the increasing demand for biopharmaceuticals owing to effective treatments like cell and gene therapy and the upswing in innovation that resulted in increased approvals. It is expected that the U.S. FDA will be approving around 10 to 20 products of cell and gene therapy each year by 2025 based on the current clinical success rates and the product pipeline.
Also, technological advancements, supportive government legislation, and increased funding for stem cell studies have propelled the adoption of 3D culture models. For instance, the 2024 Stem Cell Therapies Grant Opportunity under the Medical Research Future Fund (MRFF) aims to foster innovative research and development in stem cell therapies. The total funding available is up to USD 10 million, the funding range per project is between USD 200,000 and USD 1 million, and the maximum grant period is up to 2 years.
The cancer research segment is expected to register the fastest growth rate from 2025 to 2030. The rising prevalence of cancer and the benefits offered by 3D culture models in cancer research are expected to drive segment expansion. Moreover, the advantages of 3D media in altering cell proliferation and morphology, capturing phenotypic heterogeneity, and flexibility offered by these media further support segment expansion.
The biopharmaceutical & pharmaceutical companies segment dominated the market with a share of 46.93% in 2024. The market is segmented into biotechnology & pharmaceutical companies, academic & research institutes, hospitals, and others. The continuous growth and commercial success of biopharmaceuticals, coupled with leveraging the portfolio of the major pharmaceutical companies, have contributed to the segment growth. The 3D model offers benefits such as optimal oxygen & nutrient gradient formation and realistic cellular interactions compared to two-dimensional cellular media to study drugs. These factors facilitate the adoption of this method for drug discovery & development, fueling demand.
The academic & research institutes segment is expected to register the fastest CAGR from 2025 to 2030. Factors such as advancements in biomedical research, increasing research activities, rising industry-academia collaboration, and significant efforts from research institutions in drug modelling and screening are anticipated to accelerate segment growth. For instance, in June 2024, The Indian Institute of Science (IISc) developed a novel 3D hydrogel culture model to study tuberculosis infection and treatment strategies. This innovation provides a platform for deeper insights into host-pathogen interactions and drug efficacy, addressing critical health challenges in the region.
North America 3D cell culture market dominated the global market and accounted for 39.09% share in 2024. The market is collectively driven by the presence of advanced healthcare infrastructure, developed economies, the presence of key players, and various strategic initiatives undertaken by them. In addition, a supportive regulatory framework, government support for the development of three-dimensional culture models, and a high number of research organizations and universities investigating different stem-cells based approaches are projected to support the regional market. For instance, in April 2023, the American Cancer Society (ACS) has announced the funding of more than USD 45 million for 90 novel Extramural Discovery Science (EDS) research at 67 institutes across U.S.
The U.S. 3D cell culture market the held the largest revenue share in 2024. Due to its growing applicability, the huge chronic disease burden drives the demand for 3D cell culture techniques. Moreover, the availability of government funds and investments by private organizations is further expected to drive this vertical.
The Europe 3D cell culture market is growing due to significant investments in research and development from both public and private sectors. Many organizations are focusing on funding cancer research and other life sciences initiatives that utilize 3D cell culture technologies, further driving innovation in this field in this region.
The 3D cell culture market in Germany is one of Europe's significant industry, fueled by substantial investments from government programs like the German Research Foundation (DFG) and private-sector collaborations.
The UK 3D cell culture market is expected to grow significantly during the forecast period. The various initiatives by the government and non-government organizations to sustain competition with countries such as the U.S. and Japan are expected to contribute to further progress.
The Asia Pacific 3D cell culture market is anticipated to witness the fastest growth from 2025 to 2030. The high burden of chronic diseases, the flourishing biotechnology sector in the region, low operating costs, and rising investments by regional companies are fueling the regional market. Moreover, growing demand for cellular therapies, increasing biobanks, and strong research potential further contribute to the regional market.
The growth of the China 3D cell culture market has driven the shift toward advanced drug testing models, reducing reliance on animal testing and the increasing demand for 3D cultures in regenerative medicine and toxicology testing.
Japan 3D cell culture market is projected to witness surging growth in the coming years owing to developing markets and increasing government participation in this market space.
The 3D cell culture market in Latin America is witnessing significant growth in its biotechnology and pharmaceutical industries, spurred by increased investment in research and development. Countries like Brazil and Mexico are enhancing their healthcare infrastructures, facilitating the adoption of advanced technologies such as 3D cell cultures.
Brazil 3D cell culture market will see steady growth in the coming years due to improving the healthcare system coupled with entering new market entities is expected to drive the
Prominent players operating in the 3D cell culture industry are undertaking strategic activities such as new product launches, partnerships for product development, and investment activities to fuel market growth in the coming years.
The following are the leading companies in the 3D cell culture market. These companies collectively hold the largest market share and dictate industry trends.
View a comprehensive list of companies in the 3D Cell Culture Market
In October 2024, Univercells Technologies launched the Scale-X Nexo bioreactor, designed to improve the efficiency of cell culture process development across various therapeutic modalities.
In September 2023, Curi bio announced the launch of two platforms, that is, Nautilus and Stringray. These platforms are anticipated to assist researchers with their 2D or 3D cell cultures interrogation on electrophysiology.
In July 2023, 3D BioFibR, a Canada-based company, has received an investment of nearly USD 3.52 million to expand the facility and launch collagen fiber products used for 3D bioprinting.
In February 2023, Corning Life Sciencesannounced its plans to unveil its advanced 3D culture tools and a new Elplasia plate featuring an open-well format for easing spheroid and organoid manipulations.
In January 2023, CD BioSciences launched scaffold-based technology to help scientists in achieving organotypic co-culture and simulating layered tissue structures.
Report Attribute |
Details |
Market size value in 2025 |
USD 1.84 billion |
Revenue forecast in 2030 |
USD 3.21 billion |
Growth rate |
CAGR of 11.72% from 2025 to 2030 |
Actual data |
2018 - 2024 |
Forecast period |
2025 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2025 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Technology, application, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; Mexico, Germany; UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Argentina; South Africa; Saudi Arabia, UAE; Kuwait |
Key companies profiled |
Thermo Fisher Scientific, Inc.; Merck KGaA; PromoCell GmbH; Lonza; Corning Incorporated; Avantor, Inc.; Tecan Trading AG; REPROCELL Inc.; CN Bio Innovations Ltd; Lena Biosciences. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global 3D cell culture market report based on technology, application, end-use, and region:
Technology Outlook (Revenue, USD Million, 2018 - 2030)
Scaffold Based
Hydrogels
Polymeric Scaffolds
Micropatterned Surface Microplates
Nanofiber Base Scaffolds
Scaffold Free
Hanging Drop Microplates
Spheroid Microplates with ULA Coating
Magnetic Levitation
Bioreactors
Microfluidics
Bioprinting
Application Outlook (Revenue, USD Million, 2018 - 2030)
Cancer Research
Stem Cell Research & Tissue Engineering
Drug Development & Toxicity Testing
Others
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Biotechnology And Pharmaceutical Companies
Academic & Research Institutes
Hospitals
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
b. Key factors that are driving the 3D cell culture market growth include rising demand for organ transplantation & tissue engineering, technological advancements in scaffold-free technology, and a rise in investments and R&D funding for cell-based research.
b. The global 3D cell culture market size was estimated at USD 1.70 billion in 2024 and is expected to reach USD 1.84 billion by 2025.
b. The global 3D cell culture market is expected to grow at a compound annual growth rate of 11.72% from 2025 to 2030 to reach USD 3.21 billion by 2030.
b. Scaffold-based technology segment dominated the 3D cell culture market with a share of 48.85% in 2024. Factors such as increasing application of scaffold-based cultures in tissue engineering and regenerative medicine applications, advancements in scaffold materials and fabrication techniques, and increasing research funding and collaboration are anticipated to drive segment growth.
b. Some key players operating in the 3D cell culture market include Thermo Fisher Scientific, Inc.; Merck KGaA, PromoCell GmbH; Lonza; Corning Incorporated; Avantor, Inc.; Tecan Trading AG; REPROCELL Inc.; CN Bio Innovations Ltd; Lena Biosciences.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Technology Segment
1.1.2. Application Segment
1.1.3. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information or Data Analysis:
1.6.1. Data Analysis Models
1.7. Market Formulation & Validation
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing demand for organ transplantation & tissue engineering
3.2.1.2. Technological advancements in scaffold free technology
3.2.1.3. Rise in investments and R&D funding for cell-based research
3.2.1.4. Increasing focus on developing alternative to animal testing
3.2.2. Market Restraint Analysis
3.2.2.1. High cost associated with implementation
3.2.2.2. Lack of compatibility and consistency
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Technology Business Analysis
4.1. 3D Cell Culture Market: Technology Movement Analysis
4.2. Scaffold Based
4.2.1. Scaffold based market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.2. Hydrogels
4.2.2.1. Hydrogels market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.3. Polymeric Scaffolds
4.2.3.1. Polymeric scaffolds market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.4. Micropatterned Surface Microplates
4.2.4.1. Micropatterned surface microplates market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.5. Nanofiber Based Scaffolds
4.2.5.1. Nanofiber based scaffolds market estimates and forecasts, 2018 - 2030 (USD Million)
4.3. Scaffold Free
4.3.1. Scaffold free market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.2. Hanging Drop Microplates
4.3.2.1. Hanging drop microplates market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.3. Spheroid Microplates with ULA coating
4.3.3.1. Spheroid microplates with ULA coating market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.4. Magnetic Levitation
4.3.4.1. Magnetic levitation market estimates and forecasts, 2018 - 2030 (USD Million)
4.4. Bioreactors
4.4.1. Bioreactors market estimates and forecasts, 2018 - 2030 (USD Million)
4.5. Microfluidics
4.5.1. Microfluidics market estimates and forecasts, 2018 - 2030 (USD Million)
4.6. Bioprinting
4.6.1. Bioprinting market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. 3D Cell Culture Market: Application Movement Analysis
5.2. Cancer Research
5.2.1. Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
5.3. Stem Cell Research & Tissue Engineering
5.3.1. Stem cell research & tissue engineering market estimates and forecasts, 2018 - 2030 (USD Million)
5.4. Drug Development & Toxicity Testing
5.4.1. Drug development & toxicity testing market estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. End Use Business Analysis
6.1. 3D Cell Culture Market: End Use Movement Analysis
6.2. Biotechnology & Pharmaceutical Companies
6.2.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
6.3. Academic & Research Institutes
6.3.1. Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
6.4. Hospitals
6.4.1. Hospital market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. 3D Cell Culture Share By Region, 2024 & 2030
7.2. North America
7.2.1. North America 3D Cell Culture, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Target Disease Prevalence
7.2.2.4. U.S. 3D Cell Culture, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Target Disease Prevalence
7.2.3.4. Canada 3D Cell Culture, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Key Country Dynamics
7.2.4.2. Competitive Scenario
7.2.4.3. Target Disease Prevalence
7.2.4.4. Mexico 3D Cell Culture, 2018 - 2030 (USD Million)
7.2.4.5.
7.3. Europe
7.3.1. Europe 3D Cell Culture, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Target Disease Prevalence
7.3.2.4. UK 3D Cell Culture, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Target Disease Prevalence
7.3.3.4. Germany 3D Cell Culture, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Target Disease Prevalence
7.3.4.4. France 3D Cell Culture, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Target Disease Prevalence
7.3.5.4. Italy 3D Cell Culture, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Target Disease Prevalence
7.3.6.4. Spain 3D Cell Culture, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Target Disease Prevalence
7.3.7.4. Denmark 3D Cell Culture, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Target Disease Prevalence
7.3.8.4. Sweden 3D Cell Culture, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Target Disease Prevalence
7.3.9.4. Norway 3D Cell Culture, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific 3D Cell Culture, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Target Disease Prevalence
7.4.2.4. Japan 3D Cell Culture, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Target Disease Prevalence
7.4.3.4. China 3D Cell Culture, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Target Disease Prevalence
7.4.4.4. India 3D Cell Culture, 2018 - 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Target Disease Prevalence
7.4.5.4. Australia 3D Cell Culture, 2018 - 2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Target Disease Prevalence
7.4.6.4. Thailand 3D Cell Culture, 2018 - 2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Target Disease Prevalence
7.4.7.4. South Korea 3D Cell Culture, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America 3D Cell Culture, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Target Disease Prevalence
7.5.2.4. Brazil 3D Cell Culture, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Target Disease Prevalence
7.5.3.4. Argentina 3D Cell Culture, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. MEA 3D Cell Culture, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Target Disease Prevalence
7.6.2.4. South Africa 3D Cell Culture, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Target Disease Prevalence
7.6.3.4. Saudi Arabia 3D Cell Culture, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Target Disease Prevalence
7.6.4.4. UAE 3D Cell Culture, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Target Disease Prevalence
7.6.5.4. Kuwait 3D Cell Culture, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Merck KGaA
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. PromoCell GmbH
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Lonza
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Corning Incorporated
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Avantor, Inc.
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Tecan Trading AG
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. REPROCELL Inc.
8.4.8.1. Overview
8.4.8.2. Product Benchmarking
8.4.8.3. Strategic Initiatives
8.4.9. CN Bio Innovations Ltd.
8.4.9.1. Overview
8.4.9.2. Product Benchmarking
8.4.9.3. Strategic Initiatives
8.4.10. Lena Biosciences
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Global 3D cell culture market, by region, 2018 - 2030 (USD Million)
Table 3 North America 3D cell culture market, by country, 2018 - 2030 (USD Million)
Table 4 North America 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 5 North America 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 6 North America 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 7 U.S. 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 8 U.S. 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 9 U.S. 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 10 Canada 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 11 Canada 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 12 Canada 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 13 Mexico 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 14 Mexico 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 15 Mexico 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 16 Europe 3D cell culture market, by country, 2018 - 2030 (USD Million)
Table 17 Europe 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 18 Europe 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 19 Europe 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 20 Germany 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 21 Germany 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 22 Germany 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 23 UK 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 24 UK 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 25 UK 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 26 France 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 27 France 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 28 France 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 29 Italy 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 30 Italy 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 31 Italy 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 32 Spain 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 33 Spain 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 34 Spain 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 35 Denmark 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 36 Denmark 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 37 Denmark 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 38 Sweden 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 39 Sweden 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 40 Sweden 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 41 Norway 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 42 Norway 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 43 Norway 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 44 Asia Pacific 3D cell culture market, by country, 2018 - 2030 (USD Million)
Table 45 Asia Pacific 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 46 Asia Pacific 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 47 Asia Pacific 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 48 China 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 49 China 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 50 China 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 51 Japan 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 52 Japan 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 53 Japan 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 54 India 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 55 India 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 56 India 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 57 South Korea 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 58 South Korea 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 59 South Korea 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 60 Australia 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 61 Australia 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 62 Australia 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 63 Thailand 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 64 Thailand 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 65 Thailand 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 66 Latin America 3D cell culture market, by country, 2018 - 2030 (USD Million)
Table 67 Latin America 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 68 Latin America 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 69 Latin America 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 70 Brazil 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 71 Brazil 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 72 Brazil 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 73 Argentina 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 74 Argentina 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 75 Argentina 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 76 MEA 3D cell culture market, by country, 2018 - 2030 (USD Million)
Table 77 MEA 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 78 MEA 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 79 MEA 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 80 South Africa 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 81 South Africa 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 82 South Africa 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 86 UAE 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 87 UAE 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 88 UAE 3D cell culture market, by end use, 2018 - 2030 (USD Million)
Table 89 Kuwait 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 90 Kuwait 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 91 Kuwait 3D cell culture market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 3D cell culture market: market outlook
Fig. 9 Parent market outlook
Fig. 10 3D cell culture market driver impact
Fig. 11 3D cell culture market restraint impact
Fig. 12 3D cell culture market: technology outlook and key takeaways
Fig. 13 3D cell culture market: technology movement analysis
Fig. 14 Scaffold based market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 15 Hydrogels market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 16 Polymeric scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 Micropatterned surface microplates market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Nanofiber based scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Scaffold free market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Hanging drop microplates market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Spheroid microplates with ULA coating market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Magnetic levitation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Bioreactors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Bioprinting market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 3D cell culture market: application outlook and key takeaways
Fig. 27 3D cell culture market: application movement analysis
Fig. 28 Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Stem cell research & tissue engineering market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Drug development & toxicity testing market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 3D cell culture market: end use outlook and key takeaways
Fig. 33 3D cell culture market: end use movement analysis
Fig. 34 Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Hospitals market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 37 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 North America 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 U.S. 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Canada 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Mexico 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Europe 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 UK 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Germany 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 France 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Italy 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Spain 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Denmark 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Sweden 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Norway 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Asia Pacific 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 China 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Japan 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 India 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Thailand 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 South Korea 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Australia 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Latin America 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Brazil 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Argentina 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Middle East and Africa 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 South Africa 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Saudi Arabia 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 UAE 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Kuwait 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Market Segmentation
Report content
Qualitative Analysis
Quantitative Analysis
Research Methodology
Grand View Research employs a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. The company utilizes a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. In Addition, a recurring theme prevalent across all our research reports is data triangulation that looks market from three different perspectives. Critical elements of the methodology employed for all our studies include:
Preliminary data mining
Raw market data is obtained and collated on a broad front. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. For a comprehensive understanding of the market, it is essential to understand the complete value chain, and in order to facilitate this; we collect data from raw material suppliers, distributors as well as buyers.
Technical issues and trends are obtained from surveys, technical symposia, and trade journals. Technical data is also gathered from an intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered. As a result, the material developed contains a wide range of original data that is then further cross-validated and authenticated with published sources.
Statistical model
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression, and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, industry experience, and domain expertise.
Econometric models are generally used for short-term forecasting, while technological market models are used for long-term forecasting. These are based on an amalgamation of the technology landscape, regulatory frameworks, economic outlook, and business principles. A bottom-up approach to market estimation is preferred, with key regional markets analyzed as separate entities and integration of data to obtain global estimates. This is critical for a deep understanding of the industry as well as ensuring minimal errors. Some of the parameters considered for forecasting include:
• Market drivers and restraints, along with their current and expected impact
• Raw material scenario and supply v/s price trends
• Regulatory scenario and expected developments
• Current capacity and expected capacity additions up to 2030
We assign weights to these parameters and quantify their market impact using weighted average analysis, to derive an expected market growth rate.
Primary validation
This is the final step in estimating and forecasting for our reports. Exhaustive primary interviews are conducted, face to face as well as over the phone to validate our findings and assumptions used to obtain them. Interviewees are approached from leading companies across the value chain including suppliers, technology providers, domain experts, and buyers so as to ensure a holistic and unbiased picture of the market. These interviews are conducted across the globe, with language barriers overcome with the aid of local staff and interpreters. Primary interviews not only help in data validation but also provide critical insights into the market, current business scenario, and future expectations and enhance the quality of our reports. All our estimates and forecast are verified through exhaustive primary research with Key Industry Participants (KIPs) which typically include:
• Market-leading companies
• Raw material suppliers
• Product distributors
• Buyers
The key objectives of primary research are as follows:
• To validate our data in terms of accuracy and acceptability
• To gain an insight in to the current market and future expectations
Data Collection Matrix
Perspective |
Primary research |
Secondary research |
Supply-side |
|
|
Demand-side |
|
|
Industry Analysis Matrix
Qualitative analysis |
Quantitative analysis |
|
|
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."